These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38795774)

  • 21. A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season.
    Pelton SI; Divino V; Postma MJ; Shah D; Mould-Quevedo J; DeKoven M; Krishnarajah G
    Vaccine; 2021 Apr; 39(17):2396-2407. PubMed ID: 33810903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine against recurrent hospitalizations and mortality in relation to influenza circulation: A post-hoc analysis of the DANFLU-1 randomized clinical trial.
    Johansen ND; Modin D; Skaarup KG; Nealon J; Samson S; Dufournet M; Loiacono MM; Harris RC; Larsen CS; Jensen AMR; Landler NE; Claggett BL; Solomon SD; Landray MJ; Gislason GH; Køber L; Jensen JUS; Sivapalan P; Vestergaard LS; Valentiner-Branth P; Krause TG; Biering-Sørensen T
    Clin Microbiol Infect; 2024 Nov; 30(11):1453-1459. PubMed ID: 38286177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19.
    Balasubramani GK; Choi WS; Nowalk MP; Zimmerman RK; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Murthy K; Jackson ML; Jackson LA; Chung JR; Spencer S; Fry AM; Patel M; Flannery B;
    Vaccine; 2020 Sep; 38(42):6562-6569. PubMed ID: 32800465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors.
    Becker DL; Chit A; DiazGranados CA; Maschio M; Yau E; Drummond M
    Hum Vaccin Immunother; 2016 Dec; 12(12):3036-3042. PubMed ID: 27669017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective test-negative design.
    Zimmerman RK; Patricia Nowalk M; Dauer K; Clarke L; Raviotta JM; Balasubramani GK
    Vaccine; 2023 Aug; 41(35):5134-5140. PubMed ID: 37474406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above: Rationale and design of a real-world pragmatic randomized clinical trial.
    Hollingsworth R; Palmu A; Pepin S; Dupuy M; Shrestha A; Jokinen J; Syrjänen R; Nealon J; Samson S; De Bruijn I
    Am Heart J; 2021 Jul; 237():54-61. PubMed ID: 33722585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost Benefit of High-Dose vs Standard-Dose Influenza Vaccine in a Long-Term Care Population During an A/H1N1-Predominant Influenza Season.
    Shireman TI; Ogarek J; Gozalo P; Zhang T; Mor V; Davidson HE; Han L; Taljaard M; Gravenstein S
    J Am Med Dir Assoc; 2019 Jul; 20(7):874-878. PubMed ID: 30777631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design.
    Robison SG; Thomas AR
    Vaccine; 2018 Oct; 36(45):6683-6687. PubMed ID: 30287157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of high-dose versus standard-dose influenza vaccine in older adults.
    DiazGranados CA; Dunning AJ; Kimmel M; Kirby D; Treanor J; Collins A; Pollak R; Christoff J; Earl J; Landolfi V; Martin E; Gurunathan S; Nathan R; Greenberg DP; Tornieporth NG; Decker MD; Talbot HK
    N Engl J Med; 2014 Aug; 371(7):635-45. PubMed ID: 25119609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative vaccine efficacy of high-dose versus standard-dose influenza vaccines in preventing probable influenza in a Medicare Fee-for-Service population.
    Paudel M; Mahmud S; Buikema A; Korrer S; Van Voorhis D; Brekke L; Chit A
    Vaccine; 2020 Jun; 38(29):4548-4556. PubMed ID: 32446835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults.
    DiazGranados CA; Dunning AJ; Robertson CA; Talbot HK; Landolfi V; Greenberg DP
    Clin Infect Dis; 2016 May; 62(9):1092-1099. PubMed ID: 26908801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative and Absolute Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults-United States, 2015-2017.
    Doyle JD; Beacham L; Martin ET; Talbot HK; Monto A; Gaglani M; Middleton DB; Silveira FP; Zimmerman RK; Alyanak E; Smith ER; Flannery BL; Rolfes M; Ferdinands JM
    Clin Infect Dis; 2021 Mar; 72(6):995-1003. PubMed ID: 32067049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cluster randomized controlled trial comparing relative effectiveness of two licensed influenza vaccines in US nursing homes: Design and rationale.
    Gravenstein S; Dahal R; Gozalo PL; Davidson HE; Han LF; Taljaard M; Mor V
    Clin Trials; 2016 Jun; 13(3):264-74. PubMed ID: 26908539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects.
    Ridenhour BJ; Campitelli MA; Kwong JC; Rosella LC; Armstrong BG; Mangtani P; Calzavara AJ; Shay DK
    PLoS One; 2013; 8(10):e76318. PubMed ID: 24146855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative Effectiveness of High-Dose vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults with Cardiovascular Disease: A Prespecified Analysis of the DANFLU-1 Randomized Clinical Trial.
    Christensen J; Johansen ND; Modin D; Janstrup KH; Nealon J; Samson SI; Loiacono MM; Harris R; Larsen CS; Jensen AMR; Landler NE; Claggett BL; Solomon SD; Gislason GH; Køber L; Landray MJ; Sivapalan P; Jensen JUS; Biering-Sørensen T
    Circ Cardiovasc Qual Outcomes; 2024 Aug; ():. PubMed ID: 39215646
    [No Abstract]   [Full Text] [Related]  

  • 37. Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration Patients.
    Young-Xu Y; Van Aalst R; Mahmud SM; Rothman KJ; Snider JT; Westreich D; Mor V; Gravenstein S; Lee JKH; Thommes EW; Decker MD; Chit A
    J Infect Dis; 2018 May; 217(11):1718-1727. PubMed ID: 29452380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older.
    Falsey AR; Treanor JJ; Tornieporth N; Capellan J; Gorse GJ
    J Infect Dis; 2009 Jul; 200(2):172-80. PubMed ID: 19508159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between influenza vaccination, cardiovascular mortality and hospitalization: A living systematic review and prospective meta-analysis.
    Liu R; Fan Y; Patel A; Liu H; Du X; Liu B; Di Tanna GL
    Vaccine; 2024 Feb; 42(5):1034-1041. PubMed ID: 38267331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease: A Secondary Analysis of the INVESTED Randomized Clinical Trial.
    Peikert A; Claggett BL; Udell JA; Joseph J; Hegde SM; Kim K; Mao L; Wang T; Havighurst TC; Farkouh ME; Bhatt DL; Tattersall MC; Cooper LS; Solomon SD; Vardeny O
    JAMA Cardiol; 2024 Jun; 9(6):574-581. PubMed ID: 38583091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.